fbpx
August 29, 2025

July – September 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)

Ajovy (fremanezumab-vfrm) Emgality (galcanezumab-gnlm) Nurtec ODT (rimegepant) Ubrelvy (ubrogepant) Vyepti (eptinezumab-jjmr) Hypertension The “Warnings and Precautions”, “Adverse Reactions”, “Patient Counseling Information”, and “Patient Information” sections of […]
August 28, 2025

BeSafeRx: Resources for Consumers

Online Pharmacy Risks and Safety Precautions FDA provides additional information and resources for consumers who are thinking of buying prescription medicine online. State pharmacy boards The […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0